Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Bullock Lawrence E

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bullock Lawrence E since year 2005. The trader's CIK number is 1206868. At the time of this reporting, Bullock Lawrence E is the Chief Financial Officer of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .

Stock purchases, sales, and option exercises reported by insider Bullock Lawrence E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-03-28 BMTI Biomimetic Therapeutics, Inc. Purchase 10,000 9.00 90,000
2006-05-12 BMTI Biomimetic Therapeutics, Inc. Purchase 10,000 8.00 80,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bullock Lawrence E (Chief Financial Officer of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.